Lumina Fund Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-700
Closed -$85K 71
2023
Q2
$85K Hold
700
0.04% 70
2023
Q1
$108K Hold
700
0.05% 69
2022
Q4
$126K Hold
700
0.05% 69
2022
Q3
$83K Hold
700
0.03% 72
2022
Q2
$100K Hold
700
0.04% 67
2022
Q1
$121K Hold
700
0.04% 57
2021
Q4
$178K Buy
+700
New +$205K 0.06% 36

Other funds holding MRNA

Lumina Fund Management's MRNA Position: Q3 2023 in Review

Lumina Fund Management sold out of Moderna (MRNA) in Q3 2023, closing a stake of 700 shares — an estimated $85K sold.

Lumina Fund Management first reported a position in MRNA in Q4 2021 and held it in 7 quarters. The position peaked at $178K in Q4 2021. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Lumina Fund Management reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • Lumina Fund Management sold 700 Moderna shares in Q3 2023, an estimated $85K.
  • Lumina Fund Management first reported a position in Moderna in Q4 2021 and held it in 7 quarters.
  • Lumina Fund Management's Moderna position peaked at $178K in Q4 2021.
  • 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Lumina Fund Management's 13F filing for Q3 2023, filed 13 Nov 2023.